Olopatadine Hydrochloride Ophthalmic 2 mg/mL Solution, 1 bottle — NDC 68083-0231-01 package photo

Olopatadine Hydrochloride Ophthalmic 2 mg/mL Solution, 1 bottle

by Gland Pharma Limited · 1 BOTTLE, PLASTIC in 1 CARTON (68083-231-01) / 2.5 mL in 1 BOTTLE, PLASTIC
NDC 68083-0231-01
🏷️ FDA NDC (as labeled) 68083-231-01 billing pads the product segment with a zero
This package
Contains1 bottle Pack sizes2 compare ↓
On market Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 68083-231-01
Product NDC 68083-231
11-digit billing NDC 68083023101
SPL Set ID 9a4c58dc-aee6-441f-8081-608e4fd36193
DEA schedule Non-controlled
Marketing category EXPORT ONLY
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-08-20
Dosage form SOLUTION
Substance OLOPATADINE HYDROCHLORIDE
Why two NDCs? The FDA registers this code as 68083-231-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 68083-0231-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerGland Pharma Limited
Labeler code68083
First marketedAug 2020
Product typeBulk Ingredient
Portfolio262 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📖 What it is MedlinePlus · NLM

Prescription ophthalmic olopatadine (Pazeo) and nonprescription ophthalmic olopatadine (Pataday) are used to relieve itchy eyes caused by allergic reactions to pollen, ragweed, grass, animal hair, or pet dander. Olopatadine is in a class of medications called mast cell stabilizers. It works by preventing the release of substances that cause eye itching.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It does both, but with different products. The eye drops are for allergy-related itchy and red eyes. The nasal spray — brands like Patanase — is for seasonal allergic rhinitis, mea...
  • What exactly does olopatadine treat — is it just for eyes, or can it help my runny nose too?
  • You need to take your contacts out before you put the drops in. Wait at least 10 minutes after using the drops before you put them back in. Also, don't wear contacts at all if your...
  • Can I wear my contact lenses while using olopatadine eye drops?
📖 Read our full Olopatadine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII F5UM2KM3W7
    Benzalkonium chloride is a chemical compound that works as a preservative and antimicrobial agent in medications. It prevents bacterial and fungal growth in liquid formulations to keep the product safe during storage and use.
  • UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • UNII QTT17582CB
    A strong acid used to adjust and maintain the proper pH level in liquid medicines, ensuring stability and preventing breakdown of active ingredients.
  • UNII U725QWY32X
    Povidone K30 is a synthetic polymer made from petroleum. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in the stomach so the medicine can be absorbed.
  • UNII 451W47IQ8X
    Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 22ADO53M6F
    A mineral salt derived from phosphoric acid, used as a buffer to maintain the pH balance of the medication and help stabilize the active ingredients.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

8 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesbenzalkonium chloride 0.01%, dibasic sodium phosphate, edetate disodium, hydrochloric acid/sodium hydroxide (adjust pH), povidone, sodium chloride, and water for injection.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 1000 bottles
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Olopatadine Hydrochloride 2 mg/mL 24208-0617-01 Bausch 1 bottle $2.005 Availability likely
Leader Olopatadine Hydrochloride 2 mg/mL 70000-0716-01 CARDINAL 1 bottle $2.005 Availability likely
Olopatadine Hydrochloride 2 mg/mL 00536-1307-23 Rugby 1 bottle $2.997 Availability likely
olopatadine hydrochloride 2 mg/mL 16571-0861-25 Rising 2.5 ml $2.997 Availability likely
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 43598-0764-02 Dr. 1 bottle $2.997 Availability likely
Olopatadine Hydrochloride 2 mg/mL 46122-0671-27 Amerisource 1 bottle $2.997 Availability likely
Olopatadine Hydrochloride 2 mg/mL 68001-0530-69 BluePoint 1 bottle $2.997 Availability likely
Olopatadine Hydrochloride 2 mg/mL 68001-0674-92 BluePoint 1 bottle $2.997 Availability likely
Olopatadine Hydrochloride 2 mg/mL 70069-0491-01 Somerset 1 bottle $2.997 Availability likely
Eye Allergy Itch Relief Once Daily Relief 2 mg/mL 70677-1155-01 Strategic 1 bottle $2.997 Availability likely
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 83324-0120-25 Chain 1 bottle $2.997 Availability likely
Eye Allergy Itch Relief 2 mg/mL 70000-0053-01 CARDINAL 1 bottle $3.096 Availability likely
Pataday Once Daily Relief 2 mg/mL 00065-8150-01 Alcon 1 bottle $5.893 Availability likely
Olopatadine Hydrochloride 2 mg/mL 00363-0869-01 WALGREEN 1 bottle FDA listed
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 00363-7131-25 Walgreens 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 00363-8022-39 WALGREEN 1 bottle FDA listed
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 11673-0688-25 Target 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 11822-0063-02 RITE 1 bottle FDA listed
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 11822-9975-02 Rite 1 bottle FDA listed
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 21130-0105-02 Albertsons 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 24208-0967-01 Bausch 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 30142-0026-27 Kroger 1 bottle FDA listed
Once Daily Relief 2 mg/mL 37808-0045-25 H 1 bottle FDA listed
Eye Allergy Itch Relief Once Daily Relief 2 mg/mL 43598-0827-02 Dr. 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 46122-0824-29 AmerisourceBergen 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 46708-0710-03 Alembic 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 50090-5613-00 A-S 1 bottle FDA listed
Allergy Relief Eye Drops 2 mg/mL 51316-0675-25 CVS 1 bottle FDA listed
Retaine Allergy 5 mg/2.5mL 54799-0920-25 OCuSOFT 2.5 ml FDA listed
Olopatadine Hydrochloride Ophthalmic Solution Once Daily 2 mg/mL 55910-0137-25 DOLGENCORP, 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 58602-0007-39 Aurohealth 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 58602-0010-39 Aurohealth 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 58602-0013-39 Aurohealth 1 bottle FDA listed
Olopatadine hydrochloride 2 mg/mL 60505-6222-02 Apotex 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 62332-0502-03 Alembic 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 62332-0710-03 Alembic 1 bottle FDA listed
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 63868-0821-25 Chain 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 63941-0024-39 Best 1 bottle FDA listed
Olopatadine Hydrochloride Ophthalmic 2 mg/mLthis 68083-0231-01 Gland 1 bottle FDA listed
Eye Allergy Itch Relief 2 mg/mL 69168-0495-77 Allegiant 2 bottles FDA listed
CVS Eye Allergy Itch Relief Once Daily 2 mg/mL 69842-0269-25 CVS 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 72036-0009-39 Harris 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 72476-0851-21 Retail 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 72657-0194-11 GLENMARK 2 bottles FDA listed
Olopatadine Hydrochloride 2 mg/mL 73581-0709-02 YYBA 2 bottles FDA listed
Olopatadine Hydrochloride 2 mg/mL 76162-0044-39 TOPCO 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 79481-1001-02 Meijer 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 79903-0001-39 Wal-Mart 1 bottle FDA listed
Equate Olopatadine Hydrochloride 2 mg/mL 79903-0318-01 WAL-MART 1 bottle FDA listed
Olopatadine Hydrochloride 2 mg/mL 80539-0001-39 Allwell 1 bottle FDA listed
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 82442-0967-02 TARGET 1 bottle FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Aug 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
68083-0231-01 You're viewing this 1 BOTTLE, PLASTIC in 1 CARTON (68083-231-01) / 2.5 mL in 1 BOTTLE, PLASTIC 2020-05-20 Active
68083-0231-85 1000 BOTTLE, PLASTIC in 1 CASE (68083-231-85) / 2.5 mL in 1 BOTTLE, PLASTIC Active

Pack size FAQ

What quantity is in NDC 68083-0231-01?
NDC 68083-0231-01 contains 1 bottle — 1 bottle, plastic in 1 carton / 2.5 ml in 1 bottle, plastic.
What is the difference between NDC 68083-0231-01 and NDC 68083-0231-85?
Both are Olopatadine Hydrochloride Ophthalmic 2 mg/mL Solution — the drug itself is identical. NDC 68083-0231-01 is the 1 bottle package, while NDC 68083-0231-85 is the 1000 bottles package.
What NDC number is used to bill for this package of Olopatadine Hydrochloride Ophthalmic 2 mg/mL Solution?
Bill NDC 68083-0231-01 — the 11-digit billing format is 68083023101. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Bulk ingredient (not a finished retail product)

This is a bulk ingredient listing — not a retail prescription package

Olopatadine Hydrochloride Ophthalmic 2 mg/mL SOLUTION is listed with FDA as a bulk ingredient (a drug substance supplied for further manufacturing or licensed pharmacy compounding). It is not a finished product a patient would receive at a retail pharmacy, so consumer-style information — a patient label, retail pricing, package photos — generally does not exist for this NDC. The listing identifies the substance and package for supply-chain and regulatory purposes.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Export Only". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Can I get this product filled at a pharmacy?
Not as listed here. A bulk ingredient NDC identifies drug substance supplied for manufacturing or licensed compounding — it is not a finished, dispensable package. A pharmacy prescription would involve a finished product with its own NDC.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 68083-231-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 68083-0231-01, written without dashes as 68083023101. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 68083-0231-01, the first segment (68083) is the labeler code FDA assigned to Gland Pharma Limited; the middle segment (0231) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Gland Pharma Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1000 bottles (68083-0231-85). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Gland Pharma Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 14 words

USE temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander

⏱️ Dosage and Administration 56 words

DIRECTIONS adults and children 2 years of age and older: put 1 drop in the affected eye(s) once daily, no more than once per day if using other ophthalmic products while using this product, wait at least 5 minutes between each product replace cap after each use children under 2 years of age: consult a doctor

⚠️ Warnings 5 words

WARNINGS For external use only

🧪 Active Ingredient 9 words

ACTIVE INGREDIENT Olopatadine (0.2%) (equivalent to olopatadine hydrochloride 0.222%)

🧪 Inactive Ingredients 22 words

INACTIVE INGREDIENTS benzalkonium chloride 0.01%, dibasic sodium phosphate, edetate disodium, hydrochloric acid/sodium hydroxide (adjust pH), povidone, sodium chloride, and water for injection.

🎯 Purpose 2 words

PURPOSE Antihistamine

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.